Hello, Fool! | Login | Signup | My Fool
Aug 20, 2008 3:34 PM ET | Site Changes | Help
The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.
View All Commentary (BSX)
Recs
shravankrish (51.11) Submitted: 12/01/07 4:20 PM : Start Price: $12.21 BSX Score: 15.44
Despite the fact that Xience will probably steal marketshare from Boston Scientific over the next couple of years, Guidant gives BSX much needed diversification and once the dust settles from the acquisition, the company's finances will improve.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK